Diagnostic Performance of Fluorescein-Guided Sentinel Lymph Node Biopsy in Early Breast Cancer
Practical Solutions and Value
- Traditional methods for evaluating axillary lymph nodes in early breast cancer are resource-intensive.
- Fluorescein Sodium (FS)-guided sentinel lymph node biopsy (SLNB) offers a low-cost alternative.
- Meta-analysis shows a high Sentinel Lymph Node Identification Rate (SLN-IR) of 93% and a false negative rate of 5.6% for detecting axillary lymph node metastasis.
- Fluorescein-guided SLNB is a viable option for detecting lymph node metastases in clinically node-negative patients with early breast cancer.